Veterinary Diagnostic Equipment Market by Testings Type, Product Type, Species, End-User

Description

List of Tables

[199 Pages Report] The Veterinary Diagnostic Equipment Market size was estimated at USD 2.76 billion in 2023 and expected to reach USD 2.96 billion in 2024, at a CAGR 7.36% to reach USD 4.55 billion by 2030.

Veterinary Diagnostic Equipment comprises a diverse range of tools and systems designed specifically for diagnosing diseases, conditions, and the overall health status of animals. This equipment plays a crucial role in the veterinary sector by enabling veterinarians and veterinary technicians to accurately assess & monitor the health of pets, livestock, and other animals. Utilizing advanced technology, these diagnostic tools range from imaging equipment, such as X-ray & ultrasound machines, to clinical laboratory devices, such as blood analyzers and PCR machines. The precise and timely diagnoses provided by these instruments are essential for effective treatment planning and ensuring the well-being of animals. Increasing pet adoption and expenditure on pet care, coupled with a rising prevalence rate of diseases among animals, has increased the need for veterinary diagnostic equipment. Furthermore, the growth of animal-derived products for human consumption underlines the importance of livestock health, amplifying the need for efficient diagnostic solutions. However, the high cost of advanced diagnostic equipment and lack of awareness in emerging markets may hamper the market growth. Nevertheless, innovations in molecular diagnostics, immune-diagnostic assays, and point-of-care devices represent areas ripe for exploration and expansion, potentially opening new avenues for market growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 2.76 billion
Estimated Year [2024]	USD 2.96 billion
Forecast Year [2030]	USD 4.55 billion
CAGR (%)	7.36%

Regional Insights

The Americas region exhibits a robust market for veterinary diagnostic equipment. The United States leads in terms of market size and technological advancements, driven by high pet ownership rates, substantial veterinary healthcare expenditures, and a strong presence of leading market players. Countries in Latin America including Brazil , Mexico are experiencing growth in this sector due to increasing awareness about animal health and rising disposable incomes among pet owners. The EMEA region presents a diverse market landscape. Europe is at the forefront in terms of market maturity, driven by high standards of veterinary care, stringent animal health regulations, and significant R&D investments. The MEA region is an emerging market with potential for high growth, supported by increasing pet adoption rates, expanding livestock sectors, and growing awareness about animal health. The Asia Pacific region showcases rapid growth in the veterinary diagnostic equipment market, attributed to rising pet ownership, expanding livestock industries, and increasing expenditures on animal healthcare. Countries including China, India, Japan, and Australia are leading the growth in this region. The market is characterized by a mix of advanced technologies and basic diagnostic tools, catering to diverse needs across urban and rural areas. Growing investments in animal health infrastructure and veterinary services in the region and the expansion of local and international companies in the region, offering a wide range of diagnostic solutions, are further supporting the growth of the market.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Veterinary Diagnostic Equipment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Rising Prevalence Rate of Diseases Among Animals
- Growth in the Number of Veterinarians and Application of In-Vitro Diagnostic (IVD) Instrumentation

Market Restraints
- High Price Associated with an Animal Healthcare

Market Opportunities
- Increasing Animal Health Expenses and Pet Ownership
- Technological Advancements to Enhance Patient-Centered Specimen Collection of Diagnosis of Disease in Animals

Market Challenges
- Deficit of Veterinarians in Emerging Markets

Market Segmentation Analysis
- Testings Type: Proliferation of diagnostic imaging for diagnosing fractures, tumors, organ abnormalities and other conditions
- End-User: Increasing adaptation of veterinary diagnostic equipment in point-of-care (PoC) testing settings

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Veterinary Diagnostic Equipment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Veterinary Diagnostic Equipment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Center Point Bio-Tech's Launch of Novel Veterinary Diagnostic System Exceeds Expectations

Center Point Bio-Tech, LLC launched AlphaION, a veterinary diagnostic system that combines lab automation with artificial intelligence to enhance workflow in veterinary practices, offering comprehensive testing capabilities through its modular design, including blood, fecal, urine, and bacterial tests. AlphaION distinguishes itself as a diagnostic system that integrates Surface Acoustic Wave (SAW) technology for precise biomarker measurement and introduces in-clinic automation for bacterial culture and sensitivity testing, addressing common issues such as false negatives and testing delays associated with external labs. [Published On: 2024-01-24]

Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory

Antech expanded its UK laboratory network by opening a new, cutting-edge veterinary diagnostics facility to strengthen its presence in the region. Antech introduces to the UK its first comprehensive veterinary diagnostics solution, encompassing reference laboratory services, in-lab diagnostics, advanced imaging, technology solutions, telemedicine services, and pioneering rapid diagnostics. [Published On: 2023-11-07]

IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing

IDEXX Laboratories, Inc. has introduced a diagnostic test designed to detect kidney injury in cats and dogs, the IDEXX Cystatin B Test. This significant advancement addresses a critical need in pet healthcare, as roughly one-third of kidney issues managed by veterinarians involve injury, often challenging to diagnose due to ambiguous symptoms. The IDEXX Cystatin B Test, alongside the existing IDEXX SDMA and other renal health tests, seeks to offer a comprehensive kidney health evaluation, enabling early intervention and improved treatment outcomes. [Published On: 2023-06-15]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Veterinary Diagnostic Equipment Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Diagnostic Equipment Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert N.V., Agrolabo S.p.A., Bio-Rad Laboratories, Inc., BioChek B.V., Biomerieux SA, Carestream Health Inc., Covetrus, Inc., Diagnostic Imaging Systems, Inc., Heska Corporation, Hill-Rom Holdings, Inc., IDEXX Laboratories, Inc., IM3 Inc., IMV Technologies group, INDICAL Bioscience GmbH, Innovative Diagnostics SAS, Merck & Co., Inc., Mindray Medical International Ltd., MinXray, Inc., Neogen Corporation, Randox Laboratories, Ltd., scil animal care company GmbH, Thermo Fisher Scientific, Inc., Virbac, Inc., and Zoetis, Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Diagnostic Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Testings Type
- Bacteriology
- Clinical Chemistry Test
- Diagnostic Imaging
- Hematology
- Immunoassays
- Molecular Testing
- Parasitology
- Pathology
- Serology
- Virology

Product Type
- Consumables, Reagents & Kits
- Instruments & Devices

Species
- Avian
- Bovine
- Camelid
- Canine & Feline
- Caprine
- Equine
- Ovine
- Porcine

End-User
- Hospitals & Clinics
- Point-of-Care/In-House Testing
- Reference Laboratories
- Research Centers & Universities

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-4103B31E05FD

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising Prevalence Rate of Diseases Among Animals
  - 5.1.1.2. Growth in the Number of Veterinarians and Application of In-Vitro Diagnostic (IVD) Instrumentation
- 5.1.2. Restraints
  - 5.1.2.1. High Price Associated with an Animal Healthcare
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing Animal Health Expenses and Pet Ownership
  - 5.1.3.2. Technological Advancements to Enhance Patient-Centered Specimen Collection of Diagnosis of Disease in Animals
- 5.1.4. Challenges
  - 5.1.4.1. Deficit of Veterinarians in Emerging Markets
5.2. Market Segmentation Analysis
- 5.2.1. Testings Type: Proliferation of diagnostic imaging for diagnosing fractures, tumors, organ abnormalities and other conditions
- 5.2.2. End-User: Increasing adaptation of veterinary diagnostic equipment in point-of-care (PoC) testing settings
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Veterinary Diagnostic Equipment Market, by Testings Type

6.1. Introduction
6.2. Bacteriology
6.3. Clinical Chemistry Test
6.4. Diagnostic Imaging
6.5. Hematology
6.6. Immunoassays
6.7. Molecular Testing
6.8. Parasitology
6.9. Pathology
6.10. Serology
6.11. Virology

7. Veterinary Diagnostic Equipment Market, by Product Type

7.1. Introduction
7.2. Consumables, Reagents & Kits
7.3. Instruments & Devices

8. Veterinary Diagnostic Equipment Market, by Species

8.1. Introduction
8.2. Avian
8.3. Bovine
8.4. Camelid
8.5. Canine & Feline
8.6. Caprine
8.7. Equine
8.8. Ovine
8.9. Porcine

9. Veterinary Diagnostic Equipment Market, by End-User

9.1. Introduction
9.2. Hospitals & Clinics
9.3. Point-of-Care/In-House Testing
9.4. Reference Laboratories
9.5. Research Centers & Universities

10. Americas Veterinary Diagnostic Equipment Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Veterinary Diagnostic Equipment Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Diagnostic Equipment Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Center Point Bio-Tech's Launch of Novel Veterinary Diagnostic System Exceeds Expectations
- 13.3.2. Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory
- 13.3.3. IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio